J&J records 4.4% rise in worldwide OTC sales

17 October 2017 - Deborah Wilkes

Archived

Johnson & Johnson's worldwide OTC sales increased by 4.4% on an operational basis in the third quarter of 2017, thanks to the performance of Tylenol analgesics in the US and smoking-cessation aids elsewhere in the world.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: